These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 11134563

  • 21. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
    Freedman J, Gafni A, Garvey MB, Blanchette V.
    Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
    [Abstract] [Full Text] [Related]

  • 22. The alloimmunized patient: effective transfusion support and newer experimental approaches.
    Pamphilon DH.
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Gelb AB, Leavitt AD.
    Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 32. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
    Rioux-Massé B, Cohn C, Lindgren B, Pulkrabek S, McCullough J.
    Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
    [Abstract] [Full Text] [Related]

  • 33. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R.
    Vox Sang; 1998 Dec; 74 Suppl 2():359-63. PubMed ID: 9704468
    [Abstract] [Full Text] [Related]

  • 34. Selection of platelets for refractory patients by HLA matching and prospective crossmatching.
    Moroff G, Garratty G, Heal JM, MacPherson BR, Stroncek D, Huang ST, Ho W, Petz LD, Leach MF, Lennon SS.
    Transfusion; 1992 Sep; 32(7):633-40. PubMed ID: 1519326
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM, Summers TC, Sinor LT, Plapp FV.
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients.
    McElligott MC, Menitove JE, Duquesnoy RJ, Hunter JB, Aster RH.
    Blood; 1982 May; 59(5):971-5. PubMed ID: 6951616
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.